NasdaqCM - Nasdaq Real Time Price USD
BioXcel Therapeutics, Inc. (BTAI)
At close: November 6 at 4:00 PM EST
After hours: November 6 at 5:02 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-105,327.0000
-155,006.0000
-135,341.0000
-82,153.0000
-66,350.0000
Investing Cash Flow
--
-20.0000
-139.0000
-445.0000
-316.0000
Financing Cash Flow
34,053.0000
26,522.0000
96,237.0000
102,447.0000
247,359.0000
End Cash Position
56,271.0000
65,221.0000
193,725.0000
232,968.0000
213,119.0000
Interest Paid Supplemental Data
--
7,551.0000
2,697.0000
40.0000
27.0000
Capital Expenditure
--
-20.0000
-139.0000
-445.0000
-316.0000
Issuance of Capital Stock
34,594.0000
27,032.0000
--
100,993.0000
255,785.0000
Issuance of Debt
--
--
98,600.0000
--
--
Repurchase of Capital Stock
--
--
--
--
-9,024.0000
Free Cash Flow
-105,327.0000
-155,026.0000
-135,480.0000
-82,598.0000
-66,666.0000
12/31/2020 - 3/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KPTI Karyopharm Therapeutics Inc.
0.8866
+4.84%
APVO Aptevo Therapeutics Inc.
0.2580
-3.73%
ACET Adicet Bio, Inc.
1.3000
-0.76%
AMLX Amylyx Pharmaceuticals, Inc.
6.22
+7.06%
ALLO Allogene Therapeutics, Inc.
3.2200
+7.69%
ZNTL Zentalis Pharmaceuticals, Inc.
3.8400
+1.59%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.9330
+1.89%
FGEN FibroGen, Inc.
0.3104
+1.11%
ELEV Elevation Oncology, Inc.
0.5500
-1.79%
ATNM Actinium Pharmaceuticals, Inc.
1.9300
+2.66%